Possible mechanisms involved in the vasorelaxant effect produced by clobenzorex in aortic segments of rats.

about

Possible mechanisms involved in the vasorelaxant effect produced by clobenzorex in aortic segments of rats.

Item

http://www.wikidata.org/entity/Q41530525

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Possible mechanisms involved i ...... ex in aortic segments of rats.

@en

type

Item

label

Possible mechanisms involved i ...... ex in aortic segments of rats.

@en

prefLabel

Possible mechanisms involved i ...... ex in aortic segments of rats.

@en

P1476

Possible mechanisms involved i ...... ex in aortic segments of rats.

@en

P2093

E F Castillo-Henkel

http://www.w3.org/2001/XMLSchema#string

J D Rodríguez-Choreão

http://www.w3.org/2001/XMLSchema#string

J R Villagrana-Zesati

http://www.w3.org/2001/XMLSchema#string

J S López-Canales

http://www.w3.org/2001/XMLSchema#string

O A López-Canales

http://www.w3.org/2001/XMLSchema#string

R Morín-Zaragoza

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

Mutational analysis of ion conduction and drug binding sites in the inner mouth of voltage-gated K+ channels.

The muscarinic receptor subtypes in human blood vessels.

Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues.

Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels

Pharmacological characterization of mechanisms involved in the vasorelaxation produced by rosuvastatin in aortic rings from rats with a cafeteria-style diet.

Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells.

Ropivacaine-induced contraction is attenuated by both endothelial nitric oxide and voltage-dependent potassium channels in isolated rat aortae.

Cardiovascular risk-benefit profile of sibutramine.

Muscarinic receptor agonists and antagonists: effects on cardiovascular function.

P304

e5765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/1414-431X20175765

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Abimael González-Hernández

Jair Lozano-Cuenca

P577

2017-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28793049

http://www.w3.org/2001/XMLSchema#string

P932

5572851

http://www.w3.org/2001/XMLSchema#string